title: Medical and surgical management of chronic sinusitis.
abstract: The treatment of chronic sinusitis has four objectives: to control infection, to reduce tissue edema, to facilitate the drainage of sinus secretions and to maintain ostial permeability. Medical treatment includes antibiotics, decongestants, mucolytics, steroids and analgesics. Surgical treatment may be conservative, functional or radical. At present, "FESS" is the "Golden Standard". It is focused on the middle ostiomeatal complex and the ethmoid cells. The extent of the operation is adapted according to each case. In spite of standardization of the operative procedure, this type of surgery is risky. Most of the reported complications are minor. Major complications require an immediate aggressive medico-surgical treatment to minimize the sequelae. Precise and complete pre-operative evaluation, good preparation of the patient, meticulous and adapted surgical technique and experience acquired through a regular practice of this type of surgery play a major role to lower the risks of complications.
authors.affiliation: Catholic University of Louvain (UCL), Cliniques Universitaires UCL de Mont-Godinne, Department of Otorhinolaryngology and Head and Neck Surgery, Yvoir, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Eloy
authors.forename: B
authors.initials: B
authors.lastname: Bertrand
authors.forename: P
authors.initials: P
authors.lastname: Rombaux
mesh_terms: D000287:Administration, Topical; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002908:Chronic Disease; D004322:Drainage; D004487:Edema / Q000517:prevention & control; D004724:Endoscopy / Q000009:adverse effects / Q000379:methods; D005005:Ethmoid Sinus / Q000601:surgery; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D008443:Maxillary Sinus / Q000601:surgery; D014663:Nasal Decongestants / Q000627:therapeutic use; D010347:Patient Care Planning; D010539:Permeability; D011183:Postoperative Complications / Q000517:prevention & control; D012307:Risk Factors; D012852:Sinusitis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control / Q000601:surgery*
chemical_list: D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants; D005938:Glucocorticoids; D014663:Nasal Decongestants